US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: A 154% Potential Upside Opportunity in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company, is garnering significant attention from investors due to its promising outlook in the biotechnology sector. Headquartered in Ramsey,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 27.96% Potential Upside in the Biotech Space

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector with its robust pipeline of genetic medicines aimed at addressing diseases with high unmet..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A Compelling 32.56% Upside Potential for Investors

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 54.40% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology sector, offering innovative liquid biopsy tests and data solutions that are reshaping the..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Waters with an 8.42% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the biotechnology sector, specializing in the development of RNA-targeted therapeutics and gene therapy solutions for..

Charles River Laboratories Inte (CRL) Stock Analysis: A Deep Dive into a 25% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a notable player within the Healthcare sector, more specifically in the Diagnostics & Research industry. With its..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors in the burgeoning healthcare sector. As a prominent player in the medical devices industry, Integer..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 22% Upside Potential in the Biotech Sector

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the healthcare sector, specifically within the biotechnology industry, is capturing the attention of investors with its promising..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: 22.71% Potential Upside for This Healthcare Innovator

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, specializes in the development and commercialization of diagnostic and therapeutic products. With a market..

DaVita Inc. (DVA) Stock Analysis: A Closer Look at Its Impressive 64.85% Return on Equity

DaVita Inc. (NYSE: DVA) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.32..

Glaukos Corporation (GKOS) Stock Analysis: 34% Potential Upside Shines in the Medical Device Sector

In the ever-evolving landscape of healthcare, Glaukos Corporation (GKOS) stands out as a pioneering force in the medical devices industry. With a market capitalization of $5.99..

ICON plc (ICLR) Stock Analysis: Navigating a 31.95% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, ICON plc (ICLR) presents a compelling case for consideration. As a leading clinical research organization based in Dublin,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring the 79% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector specializing in medical devices, is garnering significant attention from investors with its innovative cardiac..

Legend Biotech Corporation (LEGN): A Biotech Powerhouse with a Potential Upside of 240%

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the biotechnology sector, offering a compelling investment story centered on its groundbreaking work in cell..

Fresenius Medical Care AG (FMS) Stock Analysis: Examining a 22.98% Potential Upside Amidst Challenges

Fresenius Medical Care AG (NYSE: FMS), a cornerstone in the healthcare sector specializing in dialysis services, stands as a pivotal player globally. With its operations spanning..

Chemed Corp (CHE) Stock Analysis: Exploring a 20% Potential Upside Amidst Market Challenges

For investors seeking stability in the healthcare sector, Chemed Corp (NYSE: CHE) presents an intriguing opportunity. With a current market capitalization of $5.2 billion, Chemed operates..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Bold Bet on Biotech with 249% Upside Potential

Soleno Therapeutics, Inc. (SLNO) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, particularly those interested in companies focusing on rare disease therapeutics...

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Powerhouse with 125% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX) has emerged as a significant player in the biotechnology sector, captivating investor interest with its innovative approach to radiopharmaceuticals. The Australian-based..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 41.93% Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, presents an intriguing case for investors seeking opportunities within the scientific..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.62% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a noteworthy player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $7.85 billion, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds